{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:15:21Z","timestamp":1792894521654,"version":"4.5.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn\u2019s and Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Judith & Stewart Colton Center"},{"name":"NIH NIDDK","award":["K23DK124570"],"award-info":[{"award-number":["K23DK124570"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Outcomes of inflammatory bowel disease (IBD) following flare complicated by enteric infection (EI) are limited by follow-up duration and insufficient assessment of the role of non-Clostridioides difficile pathogens. We compared 2-year IBD outcomes following flare with and without EI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective cohort study of adults evaluated with stool PCR testing for IBD flare. Subjects were stratified by presence of EI at flare and were matched for age, sex, and date to those without EI. The primary outcome was a composite of steroid-dependent IBD, colectomy, and\/or IBD therapy class change\/dose escalation at 2 years. Additional analyses were performed by dividing the EI group into C. difficile infection (CDI) and non-CDI EI, and further subdividing non-CDI EI into E. coli subtypes and other non-CDI EI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 137 matched subjects, of whom 62 (45%) had EI (40 [29%] CDI; 17 [12%] E. coli). Enteric infection at flare was independently associated with the primary outcome (adjusted odds ratio, 4.14; 95% confidence interval [CI], 1.62-11.5). After dividing EI into CDI and non-CDI EI, only CDI at flare was independently associated with the primary outcome (adjusted odds ratio, 4.04; 95% CI, 1.46-12.6). After separating E. coli subtypes from non-CDI EI, E. coli infection and CDI at flare were both independently associated with the primary outcome; other EI was not.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Enteric infection at flare\u2014specifically with CDI\u2014is associated with worse IBD outcomes at 2 years. The relationship between E. coli subtypes at flare and subsequent IBD outcomes requires further investigation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izad253","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T17:59:32Z","timestamp":1697824772000},"page":"1759-1766","source":"Crossref","is-referenced-by-count":11,"title":["Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-0970","authenticated-orcid":false,"given":"Abhishek","family":"Dimopoulos-Verma","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Stanford Health Care , Stanford, CA, 94305 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonwook","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, UCLA Health , Los Angeles, CA, 90024 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-7790","authenticated-orcid":false,"given":"Jordan E","family":"Axelrad","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine , New York, NY, 10016 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"issue":"6","key":"2025052401370924500_CIT0001","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/MIB.0000000000001097","article-title":"Enteric infection in relapse of inflammatory bowel disease: the utility of stool microbial PCR testing","volume":"23","author":"Axelrad","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025052401370924500_CIT0002","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A National survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2025052401370924500_CIT0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut."},{"issue":"4","key":"2025052401370924500_CIT0004","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ibd.21457","article-title":"Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease","volume":"17","author":"Ananthakrishnan","year":"2011","journal-title":"Inflamm Bowel Dis."},{"issue":"10","key":"2025052401370924500_CIT0005","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"Issa","year":"2008","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025052401370924500_CIT0006","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2016.10.024","article-title":"Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA Institute","volume":"15","author":"Khanna","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"2025052401370924500_CIT0007","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s10620-020-06071-2","article-title":"Prevalence and effect of intestinal infections detected by a PCR-based stool test in patients with inflammatory bowel disease","volume":"65","author":"Limsrivilai","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"10","key":"2025052401370924500_CIT0008","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41395-018-0211-8","article-title":"Enteric infections are common in patients with flares of inflammatory bowel disease","volume":"113","author":"Axelrad","year":"2018","journal-title":"Am J Gastroenterol."},{"issue":"10","key":"2025052401370924500_CIT0009","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ibd\/izaa336","article-title":"Comparative evaluation of conventional stool testing and multiplex molecular panel in outpatients with relapse of inflammatory bowel disease","volume":"27","author":"Hong","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2025052401370924500_CIT0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cgh.2017.10.008","article-title":"Non\u2013Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease","volume":"16","author":"Hanada","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2025052401370924500_CIT0011","volume-title":"ICD-10: international statistical classification of diseases and related health problems: tenth revision","author":"Organization WH","year":"2004"},{"issue":"5","key":"2025052401370924500_CIT0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"issue":"10","key":"2025052401370924500_CIT0013","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: definitions and diagnosis","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohn\u2019s Colitis."},{"key":"2025052401370924500_CIT0014","author":"R Core Team","year":"2013"},{"issue":"2","key":"2025052401370924500_CIT0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10620-018-5330-y","article-title":"Comparison of multiplex gastrointestinal pathogen panel and conventional stool testing for evaluation of diarrhea in patients with inflammatory bowel diseases","volume":"64","author":"Ahmad","year":"2019","journal-title":"Dig Dis Sci."},{"issue":"3","key":"2025052401370924500_CIT0016","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"67","author":"Palmela","year":"2018","journal-title":"Gut."},{"issue":"2","key":"2025052401370924500_CIT0017","doi-asserted-by":"crossref","first-page":"e00550","DOI":"10.14309\/ctg.0000000000000550","article-title":"Pathogen-specific alterations in the gut microbiota predict outcomes in flare of inflammatory bowel disease complicated by gastrointestinal infection","volume":"14","author":"Axelrad","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"2025052401370924500_CIT0018","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ibd\/izy291","article-title":"Colon surgery risk with corticosteroids vs immunomodulators or biologics in inflammatory bowel disease patients With Clostridium difficile infection","volume":"25","author":"Solanky","year":"2019","journal-title":"Inflamm Bowel Dis."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad253\/52305232\/izad253.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/10\/1759\/59547815\/izad253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/10\/1759\/59547815\/izad253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T05:37:18Z","timestamp":1748065038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/10\/1759\/7325270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,20]]},"published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad253","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2023,10,20]]}}}